Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patiño-Mercau JR"'
Autor:
Patiño-Mercau JR; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Facultad de Ciencias, University of Granada, Avda. de Fuentenueva S/N, 18071, Granada, Spain., Baliñas-Gavira C; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Present Address: Institut Curie, Paris Sciences Et Lettres Research University, Sorbonne University, INSERM U934/CNRS UMR3215, Paris, France., Andrades A; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Facultad de Ciencias, University of Granada, Avda. de Fuentenueva S/N, 18071, Granada, Spain.; Health Research Institute of Granada (Ibs.Granada), Granada, Spain., Benitez-Cantos MS; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Health Research Institute of Granada (Ibs.Granada), Granada, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain., Rot AE; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Present Address: International Postgraduate School Jožef Stefan, Ljubljana, Slovenia.; Department of Biochemistry and Molecular and Structural Biology, Jožef Stefan Institute, Ljubljana, Slovenia., Rodriguez MI; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Health Research Institute of Granada (Ibs.Granada), Granada, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain., Álvarez-Pérez JC; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Facultad de Ciencias, University of Granada, Avda. de Fuentenueva S/N, 18071, Granada, Spain.; Health Research Institute of Granada (Ibs.Granada), Granada, Spain., Cuadros M; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Health Research Institute of Granada (Ibs.Granada), Granada, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain., Medina PP; Gene Expression Regulation and Cancer Group (CTS-993), GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain. pedromedina@ugr.es.; Department of Biochemistry and Molecular Biology I, Facultad de Ciencias, University of Granada, Avda. de Fuentenueva S/N, 18071, Granada, Spain. pedromedina@ugr.es.; Health Research Institute of Granada (Ibs.Granada), Granada, Spain. pedromedina@ugr.es.
Publikováno v:
Biomarker research [Biomark Res] 2023 Mar 20; Vol. 11 (1), pp. 32. Date of Electronic Publication: 2023 Mar 20.
Autor:
Andrades A; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; and., Álvarez-Pérez JC; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; and., Patiño-Mercau JR; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain., Cuadros M; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; and.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain., Baliñas-Gavira C; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain., Medina PP; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; and.
Publikováno v:
Blood [Blood] 2022 Apr 14; Vol. 139 (15), pp. 2406-2410.
Autor:
Peinado P; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Andrades A; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Cuadros M; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Health Research Institute of Granada (ibs.Granada), 18014 Granada, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, 18016 Granada, Spain., Rodriguez MI; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Health Research Institute of Granada (ibs.Granada), 18014 Granada, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, 18016 Granada, Spain., Coira IF; School of Pharmaceutical Sciences, University of Geneva, 1211 Geneva, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva, Switzerland., Garcia DJ; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, 18016 Granada, Spain., Álvarez-Perez JC; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Baliñas-Gavira C; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Arenas AM; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Patiño-Mercau JR; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Sanjuan-Hidalgo J; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain., Romero OA; Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, 08908 Barcelona, Spain., Montuenga LM; Solid Tumors Program, Centro de Investigación Médica Aplicada and Department of Pathology, Anatomy and Physiology, University of Navarra Pamplona, 31009 Pamplona, Spain.; Navarra's Health Research Institute (IDISNA) and CIBERONC, 31008 Pamplona, Spain., Carretero J; Department of Physiology, University of Valencia, 46100 Burjassot, Valencia, Spain., Sanchez-Cespedes M; Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, 08908 Barcelona, Spain., Medina PP; Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Health Research Institute of Granada (ibs.Granada), 18014 Granada, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Dec 10; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 10.